Brian Osler
Cardiovascular Disease · Philadelphia, PANPI 1619469095
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,145 of the $10,281 with a category attached, or 69.5%. 23 manufacturers reported payments, led by Abbott at 35.3% of the total. 2025 is the largest year on record at $6,054, 6.9 times the $879 reported in 2022.
Across 197 payments — averaging $52.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Medtronic$2K
- Actelion Pharmaceuticals US, Inc.$984
- Boston Scientific$729
- Abiomed$473
- Novartis$340
- plus $2K from 17 others
What the payments were for
- Travel & lodging$2,62225%
- Food & beverage$7,14569%
- Education$5155%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 34 | $3,627 |
| Medtronic | 29 | $1,981 |
| Actelion Pharmaceuticals US, Inc. | 15 | $984 |
| Boston Scientific | 32 | $729 |
| Abiomed | 13 | $473 |
| Novartis | 18 | $340 |
| Shockwave Medical, Inc | 5 | $264 |
| Johnson & Johnson | 7 | $246 |
| Novo Nordisk | 3 | $243 |
| Pfizer | 9 | $221 |
| Amgen | 6 | $157 |
| Cardiva Medical, Inc. | 1 | $145 |
| Ancora Heart, Inc. | 1 | $134 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $126 |
| E.r. Squibb & Sons, L.L.C. | 3 | $123 |
| Sanofi-aventis U.S. LLC | 1 | $109 |
| Teleflex LLC | 2 | $98 |
| Impulse Dynamics (USA) Inc. | 3 | $91 |
| Boehringer Ingelheim | 3 | $66 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $64 |
| Philips North America LLC | 1 | $24 |
| Penumbra, Inc. | 1 | $22 |
| AstraZeneca | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NAVITOR$1,320
- MitraClip$1,319
- UPTRAVI$614
- OPSUMIT$614
- SYMPLICITY G3$565
- COREVALVE EVOLUT R$447
- ENSITE$268
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$164
- ONYX FRONTIER$161
- Cardiva VASCADE MVP VVCS 6-12F$145
- AccuCinch$134
- XARELTO$125
- AVVIGO Guidance System$119
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$107
- Ozempic$104
How this compares
$10,281 in reported general payments places this provider in the 85th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitroglycerin | 14 | $435 |
| Metoprolol Tartrate | 22 | $80 |
| Atorvastatin Calcium | 15 | $61 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Philadelphia
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Dean KaralisPhiladelphia$385K
- Manavendra BakhshiPhiladelphia$250K
- Philip HainesPhiladelphia$170K
- Julio ChirinosPhiladelphia$145K
- Michael MillerPhiladelphia$133K
- Nehal MehtaPhiladelphia$129K
- Garo GaribianPhiladelphia$115K
- Norman FeinsmithPhiladelphia$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.